GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jafron Biomedical Co Ltd (SZSE:300529) » Definitions » 3-Year EPS without NRI Growth Rate

Jafron Biomedical Co (SZSE:300529) 3-Year EPS without NRI Growth Rate : -19.60% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Jafron Biomedical Co 3-Year EPS without NRI Growth Rate?

Jafron Biomedical Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.35.

During the past 12 months, Jafron Biomedical Co's average EPS without NRI Growth Rate was -27.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -19.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 7.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Jafron Biomedical Co was 49.50% per year. The lowest was -19.60% per year. And the median was 16.50% per year.


Competitive Comparison of Jafron Biomedical Co's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Jafron Biomedical Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jafron Biomedical Co's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jafron Biomedical Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Jafron Biomedical Co's 3-Year EPS without NRI Growth Rate falls into.



Jafron Biomedical Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Jafron Biomedical Co  (SZSE:300529) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Jafron Biomedical Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Jafron Biomedical Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Jafron Biomedical Co (SZSE:300529) Business Description

Traded in Other Exchanges
N/A
Address
No. 98, Science and Technology 6th Road, High-tech Zone, Guangdong Province, Zhuhai, CHN, 519085
Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.

Jafron Biomedical Co (SZSE:300529) Headlines

No Headlines